The latest in cystic fibrosis genetic testing

This issue of partumpost from the Reproductive Genetics Division at Victorian Clinical Genetics Services (VCGS) explores the latest improvements in genetic testing for cystic fibrosis the most common inherited life shortening genetic condition affecting Australian children.

Read about the technology advances at VCGS that allow greater detection of cystic fibrosis variants and the science that supports carrier screening and diagnostic testing; helping practitioners provide targeted clinical treatments to further improve outcomes for patients and their families.

VCGS welcomed the new Medicare funding made available 1 July for individuals who have a close family history or clinical suspicion of cystic fibrosis, including prenatal diagnosis.

Read the partumpost